ELRIG announces keynote speakers for Gothenburg conference
ELRIG has announced the keynote speakers for its ‘Advances in Cell-Based Screening 2026’ conference.
Professor Hazel Screen (Queen Mary University of London) and Dr Dave Powell (Relation Therapeutics) will deliver the keynote presentations during the free-to-attend event, which takes place on 6 and 7 May at AstraZeneca in Gothenburg, Sweden.
ELRIG is aiming to bring together scientists from across pharma, biotech, academia, and the supplier ecosystem to discuss what is needed to engineer the post-animal drug discovery pipeline.
Screen specialises in organ-on-chip technologies to explore the aetiology of health and disease in musculoskeletal and cardiovascular systems. Her research examines healthy and pathological tissue structure-function relationships and their impact on cell metabolism, developing new models within which to explore fundamental tissue mechanics and biology questions as well as routes to new treatments and drug development.
Meanwhile, Powell is President of Drug Discovery at Relation Therapeutics, where he leads experimental drug discovery efforts, including functional genomics, tissue profiling, and target validation, and shapes the company’s early pipeline and future modalities.
“What really excites me about this year’s conference is that we have a very future-looking programme — it’s really about how we can enable a post-animal testing paradigm and embrace AI,” said Fredrik Edfeldt, Conference Director at ELRIG, and Director, Mechanistic Biology & Profiling at AstraZeneca.
“We are honoured to have Prof Hazel Screen and Dr Dave Powell share their insights with us during the keynotes. We look forward to welcoming ELRIG’s drug discovery community to Gothenburg!”
